In Type 1 Diabetes, Cardiac Measures Improved After Pancreas Transplant Clinical Endocrinology News Digital Network The majority (77%) had induction therapy with basiliximab; the rest had antithymocyte globulin (rabbit) induction. The maintenance immunosuppressant regimen was a combination of mycophenolate mofetil, tacrolimus, and steroids. At last follow-up ... |
